Latest Diabetes: Misc. news
ASCO: GLP-1 Receptor Agonists May Reduce Risk for Obesity-Related Cancer, All-Cause Death
posted May 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Novo Nordisk, U.S. Biotech Company Team Up to Create Obesity Pills
posted May 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Risk of Obesity-Related Cancer Similar for GLP-1 Receptor Agonists and Bariatric Surgery
posted May 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Preoperative SGLT2 Inhibitor Users Have Increased Risk for Postoperative Euglycemic Ketoacidosis
posted May 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions Related Articles
Spinal Cord Stimulation Cuts Pain, Improves Sensation With Diabetic Nerve Damage 
Very Low-Carb Diet Shows Greater Cardiometabolic Benefits Than Other Diets .jpg)
Time-Restricted Eating May Help Patients With Type 1 Diabetes 
Vascular Burden in Midlife Linked to Increased Risk for Dementia, Death Monthly Specialist Briefings
Stay Connected
